1. Introduction {#sec1}
===============

Despite many causes of erectile dysfunction (ED), such as neurovascular injury, diabetes, vascular disease, drugs and substance abuse, and testosterone deficiency, hyperlipidemia due to high-fat diets (HFD) is considered one of the most important risk factors \[[@B1]\]. Prevalence of ED has increased linearly with the severity of hyperlipidemia \[[@B2]\]. Elevated levels of lipids in the blood is harmful, because lipids exposed to oxygen will go to the peroxidation process, which is a chain reaction that contributes to produced reactive oxygen species (ROS). Increased oxidative stress, resulting from elevated ROS production, appears to play an important role in hyperlipidemia-associated ED \[[@B3]\].

Hydrogen sulfide (H~2~S) was considered a toxic pollutant until 2001, when it was firstly recognized as a mediator of vasodilation \[[@B4]\]. H~2~S, the third most important biological gasotransmitter after nitric oxide (NO) and carbon monoxide (CO), is mainly synthesized endogenously from L-cysteine by two enzymes: cystathionine *β*-synthase (CBS) and cystathionine *ɣ*-lyase (CSE) in human penile tissue \[[@B5]\]. Recently, another enzyme, 3-mercaptopyruvate sulphurtransferase (3-MST), has been proposed to synthesize H~2~S \[[@B6]\]. Evidences suggest that H~2~S exerts important biophysiological effect on erectile dysfunction. A study in a nonhuman primate model showed that administration of sodium hydrosulfide hydrate (H~2~S donor) increases intracavernosal pressure (ICP) and penile length \[[@B7]\]. Such proerectile effect of H~2~S has also been observed in other animal model \[[@B8]\], whereas CSE or CBS inhibitors result in decrease in ICP and contraction of the corpus cavernosum (CC) \[[@B5]\], suggesting an indispensable role for CSE and CBS in the biophysiological effect of H~2~S. Recent study suggested that Western high-fat diet induces oxidative stress, which occurs alongside a reduction of CSE expression and H~2~S production in the vascular system \[[@B9]\]. However, limited information has reported on the endogenous H~2~S system in hyperlipidemia-associated ED.

Sodium tanshinone IIA sulfonate (STS) is a water-soluble derivative of tanshinone IIA, which is the lipophilic diterpene that is isolated from the root of Salvia miltiorrhiza (Danshen) plant. This plant is a traditional Chinese medicinal herb, which is effective in the treatment of various cardiovascular diseases (CVD), such as hyperlipidemia, ischemic stroke, and myocardial infarctions \[[@B10]\]. STS was found to increase antioxidant capacity by induction of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) expression, which is involved in interference against oxidative stress \[[@B11]\].

Since H~2~S is an important regulator of erectile function and a proerectile molecule, examining how hyperlipidemia and subsequent oxidative stress affect its production and synthetic enzymes will examine whether or not H~2~S donors have the potential to be beneficial therapeutic agents for hyperlipidemia-associated ED. In addition, given the antioxidative effect of STS, we hypothesized that STS would have an ameliorating effect on ED in rats with hyperlipidemia through increasing H~2~S production by antioxidant actions of STS. Therefore, our current study will evaluate the involvement of STS\'s antioxidative effect in mediating H~2~S formation under hyperlipidemia or oxidative stress conditions, using a HFD-fed hyperlipidemia rat model in vivo and a hydrogen peroxide- (H~2~O~2~-) stimulated oxidative stress cavernosal smooth muscle cell (CSMC) model.

2. Materials and Methods {#sec2}
========================

2.1. Animals and Experimental Design {#sec2.1}
------------------------------------

All procedures were approved by the Animal Care and Use Committee of Southern Medical University (Guangzhou, China). The rats were maintained under a standard condition of temperature (22-25°C), a humidity of 60% ± 10%, and a 12-hour light/dark cycle. In all, a total of 36 male Sprague-Dawley rats weighing 250-300 g were randomized into 3 groups (12 in each group): normal control group (NC); high-fat diet group (HFD); and HFD treated with STS (10 mg/kg/day, intraperitoneal injection). To induce the hyperlipidemia models, the rats were fed with high-fat diet for 16 weeks continually. The ingredients in high-fat diet included 2% cholesterol, 10% lard, 10% egg yolk powder, and 79% standard rat chow (Zeigler Brothers, Gardner, PA, USA). The control rats received the basal diet at the same time.

2.2. Erectile Function Evaluation {#sec2.2}
---------------------------------

After the 12-week treatment, erectile function was assessed using intracavernosal pressure (ICP) and mean arterial pressure (MAP) tests as previously reported \[[@B12]\]. Briefly, while under anesthesia, the bilateral cavernous nerves were exposed and a bipolar steel electrode was used for nerve stimulation. The corpora at the middle of penile shaft were cannulated with a 25-G needle containing heparin (100 U/ml) connected to a pressure transducer (Biopac Systems Inc., Goleta, California, USA) to record ICP. Stimulation parameters were 5 mA, 20 Hz, plus 0.2 ms, and duration of 60 s. The mean MAP was calculated after electrical stimulation. The erectile evaluation was measured as mean ICP, MAP, and the ratio of ICP and MAP. The mean ICP and MAP were recorded using AcqKnowledge®4.4 software (Biopac Systems Inc. Goleta, California, USA). After data recording, the blood samples and the shaft of the penis were harvested for analysis.

2.3. Cell Culture and Treatment {#sec2.3}
-------------------------------

Primary CSMC were isolated from the corpus cavernosum of male Sprague-Dawley rats and identified as previously reported \[[@B13]\]. Isolated CSMC were cultured in DMEM containing 20% fetal bovine serum (Invitrogen, Carlsbad, CA, USA) at 37°C and 5% CO~2~. The purity and identity of CSMC were verified using a monoclonal antibody against calponin (1 : 100, Santa Cruz, USA). Cells from passages 3-4 were used in all experiments. To evaluate the protective effects of STS, the cells were pretreated with different doses of STS for 2 hours before H~2~O~2~ was added to the medium. The CSMC were then exposed to 100 *μ*M/ml H~2~O~2~ for 12 hours.

2.4. Cell Viability Assay {#sec2.4}
-------------------------

The cell viability of CSMC was determined by using a CCK8 assay kit (Dojindo, Japan) according to the manufacturer\'s instruction. Briefly, the cells (5,000 cells/well) were seeded in 96-well plates, cultured overnight, and treated with H~2~O~2~ (0-400 *μ*M/ml) for 6, 12, and 18 hours or STS (0-60 *μ*g/ml) for 48 hours. Subsequently, CCK8 solution (10 *μ*l) was added to each well and incubated for 2 hours. The absorbance at 450 nm was read in a microplate absorbance reader (Thermo Scientific, Waltham, MA). Cell viability was presented as percentage of normal control cells.

2.5. H~2~S Measurement {#sec2.5}
----------------------

Levels of H~2~S in tissues or cells were measured as previously described \[[@B14]\]. The penile tissue or CSMC were homogenized in 2 ml of 100 mM potassium phosphate buffer (pH 7.4). Homogenates (430 *μ*l) were added in a reaction mixture (500 *μ*l) containing 2 mM pyridoxal 5′\'-phosphate (20 *μ*l), 10 mM L-cysteine (20 *μ*l), and PBS (30 *μ*l). The reaction was performed at 37°C for 30 min in tightly sealed Eppendorf vials. Zinc acetate (1%, 250 *μ*l) was then injected to trap generated H~2~S followed by trichloroacetic acid (10%, 250 *μ*l) to precipitate protein and thus stop the reaction. Subsequently, N,N-dimethyl-p-phenylenediamine sulfate (NNDPD) (20 mM, 133 *μ*l) in 7.2 M HCl and FeCl~3~ (30 mM, 133 *μ*l) in 1.2 M HCl were added, and absorbance (670 nm) of aliquots of the resulting solution was determined. All samples were assayed in duplicate, and H~2~S concentration was calculated against a calibration curve of NaHS (3.125-250 *μ*M) and expressed in *μ*M/g.

Plasma was centrifuged at 4000 rpm for 4 min at 4°C. Supernatant (100 *μ*l) was added to a tube containing zinc acetate (1%, 250 *μ*l) and distilled water (400 *μ*l). The reaction mixture was incubated at 37°C for 30 min with NNDPD (20 mM, 133 *μ*l) in 7.2 M HCl and FeCl~3~ (30 mM, 133 *μ*l) in 1.2 M HCl. The reaction was stopped, and the samples were then centrifuged at 14,000 rpm for 10 min at 4°C. The absorbance (670 nm) of aliquot of the resulting supernatant was read. Method of measurement of concentration was the same as mentioned above, and the plasma H~2~S concentration was expressed in *μ*M.

2.6. WSP-1 {#sec2.6}
----------

To verify the results of extracellular H~2~S, intracellular H~2~S contents of the penile tissue or CSMC were visualized using the fluorescent probe WSP-1 (Cayman Chemical, Ann Arbor, MI, USA) as previously reported with some modifications \[[@B15]\]. Briefly, cells or paraffin section of tissues were washed with PBS for three times and incubated with 150 *μ*M WSP-1 at 37°C for 30 min in the dark. The fluorescence intensity was observed by Olympus laser scanning confocal microscopy and analyzed by ImageJ software (National Institutes of Health, Bethesda, MD, USA).

2.7. Immunofluorescence Analysis and Confocal Microscopy {#sec2.7}
--------------------------------------------------------

For immunofluorescence analysis, fresh tissues were immersed in OCT (Leica Biosystems, Buffalo Grove, IL, USA), frozen in liquid nitrogen, and stored at -80°C. The midshaft of the penis was used to prepare 5 *μ*m sections, which were adhered to slides. Then, the tissue sections and CSMC grown on coverslips were fixed with 4% paraformaldehyde for 15 min, permeabilized in 0.2% Triton X-100 for 10 min, and blocked for 1 h with 1% BSA. Thereafter, cells were incubated with primary antibody overnight at 4°C, followed by double staining of secondary antibodies at 37°C for 1 hour. The information for antibodies is listed in [Table 1](#tab1){ref-type="table"}. Nuclei were stained with DAPI (Abcam, Cambridge, MA, USA). Images were captured using Olympus laser scanning confocal microscopy.

2.8. Biochemical Assay {#sec2.8}
----------------------

The CSMC and the penile tissue were homogenized in Tris-HCl buffer (pH = 7.4) and centrifuged at 14,000 rpm for 10 min at 4°C. The supernatants were collected for biochemical analysis. Malondialdehyde (MDA), glutathione (GSH), and superoxide dismutase (SOD) were measured using three commercial detection kits according to the manufacturer\'s instructions and previously described methods \[[@B16]\].

Other serum markers including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were spectrophotometrically measured using commercial assay kits as described before \[[@B17]\].

2.9. Western Blotting {#sec2.9}
---------------------

The expression of HO-1, Nrf2, CSE, CBS, and 3-MST was determined by Western blotting according to previously described methods \[[@B18]\]. The information for the primary antibodies is listed in [Table 1](#tab1){ref-type="table"}. Secondary antibodies were purchased from Abbkine Inc. (catalog \# A21010, \# A21020, USA) and diluted at 1 : 30,000. Nuclear protein was isolated from the cells using a nuclear extraction kit following the manufacturer\'s instructions. Blots were analyzed with an enhanced chemiluminescence detection system.

2.10. Statistical Analysis {#sec2.10}
--------------------------

Statistical analysis was performed with the SPSS version 21.0 software for Windows. Results were recorded as mean ± standard error (SEM). Given the skewed distribution of data and the modest sample size, the nonparametric Kruskal--Wallis test and Mann--Whitney *U* test were used to assess statistical significance. *P* \< 0.05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. Effect of STS on Body Weight and Serum Lipid Levels {#sec3.1}
--------------------------------------------------------

The body weight of HFD rats was significantly higher than that of the NC control rats 16 weeks after feeding (*P* \< 0.05, [Figure 1(a)](#fig1){ref-type="fig"}). The animals fed high-fat diet showed significantly higher levels of all the serum lipids levels except for HDL-C, which showed a reduction (*P* \< 0.05, [Figure 1(b)](#fig1){ref-type="fig"}). The body weight gain observed in the rats treated with STS did not show significant changes (*P* \> 0.05, [Figure 1(a)](#fig1){ref-type="fig"}). However, STS treatment significantly reduced the TG and TC levels and increased the HDL-C level (*P* \< 0.05, [Figure 1(b)](#fig1){ref-type="fig"}).

3.2. Impact of STS on Impaired Erectile Function in HFD Rats {#sec3.2}
------------------------------------------------------------

Erectile function was significantly decreased in the HFD group, as evidenced by decreased average ICP and ICP/MAP ratio relative to NC rats (*P* \< 0.05, [Figure 2(a)](#fig2){ref-type="fig"}). STS treatment significantly improved erectile function greater than 1.5-fold compared to that in rats in the HFD group (*P* \< 0.05, [Figure 2(b)](#fig2){ref-type="fig"}).

3.3. H~2~S Level and Endogenous H~2~S Generation in HFD Rats {#sec3.3}
------------------------------------------------------------

As can be seen from [Figure 3](#fig3){ref-type="fig"}, a significant decrease in the blood and penile levels of H~2~S was detected in the HFD rats, compared to that in NC rats (*P* \< 0.05, Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}). The STS treatment markedly elevated the H~2~S level in the plasma and penile tissue. (*P* \< 0.05, Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}) Endogenous H~2~S generation in the penile tissue was measured by specific fluorescent probe WSP-1. Compared to the control, the decreased fluorescent density was observed in corpus cavernosum tissue of HFD rats. WSP-1 fluorescent density increased significantly after STS treatment, which suggested the elevation of endogenous H~2~S generation in the corpus cavernosum induced by STS treatment (*P* \< 0.05, [Figure 3(c)](#fig3){ref-type="fig"}).

3.4. Expression of H~2~S Synthetic Enzymes in HFD Rats {#sec3.4}
------------------------------------------------------

As evidenced by the significant decrease in expression of CSE and CBS in the penile tissue of the HFD rats as compared to NC rats, hyperlipidemia inhibited the expression of these two H~2~S synthetic enzymes (*P* \< 0.05, Figures [4(a)](#fig4){ref-type="fig"} and [4(b)](#fig4){ref-type="fig"}). After STS treatment, the STS group showed significant regeneration of CSE and CBS (*P* \< 0.05, Figures [4(a)](#fig4){ref-type="fig"} and [4(b)](#fig4){ref-type="fig"}). The results were also confirmed by Western blot (*P* \< 0.05, [Figure 4(c)](#fig4){ref-type="fig"}). Double immunofluorescence staining revealed colocalization of H~2~S synthetic enzymes (CSE and CBS) and smooth muscle markers (*α*-SMA and calponin). As shown in [Figure 4(c)](#fig4){ref-type="fig"}, neither hyperlipidemia nor STS treatment had significant effect on the expression of 3-MST in the penile tissue.

3.5. Antioxidative Capability in Serum and Penile Tissue {#sec3.5}
--------------------------------------------------------

As depicted in Figures [5(a)](#fig5){ref-type="fig"}--[5(c)](#fig5){ref-type="fig"}, there is a significant elevation in MDA and decline in GSH and SOD levels in serum of HFD rats compared with control rats. Treatment with STS remarkably returned this alteration to normalcy (*P* \< 0.05, Figures [5(a)](#fig5){ref-type="fig"}--[5(c)](#fig5){ref-type="fig"}). Similarly, the STS treatment also significantly elevated the GSH level and reduced MDA contents in the penile tissue (*P* \< 0.05, Figures [5(d)](#fig5){ref-type="fig"}--[5(f)](#fig5){ref-type="fig"}). As shown in [Figure 5(d)](#fig5){ref-type="fig"}, the expression rate of antioxidants Nrf2 and HO-1 in the penile tissue of HFD rats was higher compared to that of NC rats. These antioxidants were further expressed with STS treatment (*P* \< 0.05, [Figure 5(g)](#fig5){ref-type="fig"}). Double immunofluorescence staining showed that HO-1 was mainly expressed in the smooth muscle tissue, which was marked by calponin antibody. The density of HO-1-positive staining in the STS group was significantly higher than that in the HFD group (*P* \< 0.05, [Figure 5(h)](#fig5){ref-type="fig"}).

3.6. H~2~O~2~-Induced Oxidative Stress via the Nrf2/HO-1 Pathway in CSMC {#sec3.6}
------------------------------------------------------------------------

As demonstrated by the MTT assay, no significant change in CSMC viability was observed after treatment with lower concentrations of STS (0-10 *μ*g/ml) even for 48 hours (*P* \> 0.05, [Figure 6(a)](#fig6){ref-type="fig"}). In addition, we investigated CSMC death after treatment with different concentrations of H~2~O~2~ and found that H~2~O~2~ induced cell death in a dose-dependent and time-dependent manner ([Figure 6(b)](#fig6){ref-type="fig"}). As shown in [Figure 6(c)](#fig6){ref-type="fig"}, H~2~O~2~ caused an increase of Nrf2 nuclei content and decrease of Nrf2 cytoplasmic content compared to the control group (*P* \< 0.05, [Figure 6(c)](#fig6){ref-type="fig"}). Pretreatment of STS promoted Nrf2 translocation from the cytoplasm to the nucleus dose dependently, reaching a maximum translocation at 10 *μ*g/ml in H~2~O~2~-treated CSMC (*P* \< 0.05, Figures [6(d)](#fig6){ref-type="fig"} and [6(e)](#fig6){ref-type="fig"}). Also, Western blot showed that the increase in HO-1 expression in CSMC exposed to H~2~O~2~ with different doses of STS pretreatment coincided with increased Nrf2 nuclear protein levels (*P* \< 0.05, [Figure 6(f)](#fig6){ref-type="fig"}). The levels of MDA were markedly increased, and the content of SOD and GSH was decreased in H~2~O~2~-treated cells compared with the control (*P* \< 0.05, Figures [6(g)](#fig6){ref-type="fig"}--[6(i)](#fig6){ref-type="fig"}). Pretreatment with STS significantly reversed the effect of H~2~O~2~ on the oxidative status of CSMC (MDA, SOD, and GSH) (*P* \< 0.05, Figures [6(g)](#fig6){ref-type="fig"}--[6(i)](#fig6){ref-type="fig"}). Moreover, all results of the NC+STS group suggested that STS treatment did not significantly affect the indices of antioxidant enzymes under normal conditions (*P* \> 0.05, Figures [6(g)](#fig6){ref-type="fig"}--[6(i)](#fig6){ref-type="fig"}).

3.7. H~2~S Level and Expression of H~2~S-Producing Enzymes in H~2~O~2~-Treated CSMC {#sec3.7}
-----------------------------------------------------------------------------------

As shown in [Figure 7(a)](#fig7){ref-type="fig"}, the H~2~S level was significantly decreased following H~2~O~2~ treatment as compared to control (*P* \< 0.01, [Figure 7(a)](#fig7){ref-type="fig"}). STS showed the tendency to dose dependently increase the H~2~S level in H~2~O~2~-treated CSMC (*P* \< 0.05, [Figure 7(a)](#fig7){ref-type="fig"}). To further detect the intracellular H~2~S production, WSP-1 was used. Compared to the control, the decreased WSP-1 fluorescent density was observed in H~2~O~2~-treated CSMC (*P* \< 0.05, Figures [7(b)](#fig7){ref-type="fig"} and [7(c)](#fig7){ref-type="fig"}). STS pretreatment was found to enhance the intracellular H~2~S content in H~2~O~2~-treated CSMC (*P* \< 0.05, Figures [7(b)](#fig7){ref-type="fig"} and [7(c)](#fig7){ref-type="fig"}). As determined using immunofluorescence staining, expression of H~2~S-producing enzymes (CSE and CBS) in the penile tissue was significant lower in the H~2~O~2~-treated group when compared to the control group (*P* \< 0.05, Figures [8(a)](#fig8){ref-type="fig"}--[8(d)](#fig8){ref-type="fig"}). STS-treated group showed markedly more H~2~S-producing enzyme recovery than that of H~2~O~2~-treated group (*P* \< 0.05, Figures [7(a)](#fig7){ref-type="fig"}--[7(d)](#fig7){ref-type="fig"}). This was also confirmed by Western blot (*P* \< 0.05, [Figure 8(e)](#fig8){ref-type="fig"}).

4. Discussion {#sec4}
=============

In this study, we demonstrated that *in vivo* and in vitro STS treatment elicited a protective effect against the increased oxidative stress seen in H~2~O~2~-treated CSMC and in penile tissues of HFD-fed rat with hyperlipidemia and, furthermore, that the activation of Nrf2/HO-1 pathway is involved in this protective process. In addition, we provide the first molecular evidence that hyperlipidemia and H~2~O~2~ induces oxidative stress, and this occurs alongside a reduction of H~2~S production and CSE and CBS expression *in vivo* or *in vitro*, which was attenuated by STS treatment, suggesting an antioxidative role of STS. Thus, this study provides significant insights into how STS ameliorated ED in hyperlipidemia rat model and the role of oxidative stress on H~2~S generation *in vivo* and *in vitro*.

HFD-fed rat model has been widely adopted as an experimental method to induce the hyperlipidemia model \[[@B17]\]. The HFD feeding caused a significant increase in body weight and blood fat over the 16-week feeding period. Our findings suggested that administration of STS is able to improve blood lipid profiles (TC, TG, and HDL-C) in the HFD-fed rats, although there is no difference in the body weight. In addition, the activities of antioxidant enzymes (SOD and GSH) and lipid contents (MDA) in the penis and blood were measured to investigate the antioxidant effect of STS on penile tissue damage in the HFD-induced hyperlipidemia rat model. After 16 weeks of the high-fat diet, serum levels of MDA went higher, accompanied with the levels of SOD and GSH going down. The increased MDA and decreased antioxidant enzyme levels (SOD and GSH) confirmed the occurrence of oxidative damage in the penile tissue of the HFD group. This alteration was also observed in the HFD-fed rat model in other study \[[@B19]\]. However, remarkable increases in the SOD and GSH and noteworthy reduction in MDA were observed after treatment with STS. Based on these experimental results, it is demonstrated that STS reduced oxidative stress in the penis caused by high-fat diet, which may explain the recovery of erectile function.

Nrf2 is a key modulator of redox balance and signaling, which drives the expression of a battery of genes that protect against oxidative stress, including GSH, SOD, and HO-1 \[[@B20]\]. HO-1, the best known downstream effector of Nrf2, is regarded as one of the most important intracellular antioxidant mechanisms \[[@B11]\]. Activation of the Nrf2/HO-1 antioxidant pathway contributes to protection from a variety of human diseases \[[@B11], [@B20], [@B21]\]. The present study found that hyperlipidemia increases the protein levels of Nrf2 and HO-1 in the penile tissue, which is reflexively activated when suffering from external oxidative stress. In addition, STS could significantly increase the expression of Nrf2 and HO-1, which suggested STS enhanced resistance to oxidative stress in HFD rats. Similar to our results, accumulating evidence has demonstrated that activation of the Nrf2/HO-1 pathway can play a pivotal role in protecting the penis against oxidative stress \[[@B22]\].

Under basal conditions, the activity of Nrf2 is inhibited by Keap1, and upon exposure of cells to oxidative stress, Nrf2 translocates from the cytoplasm to the nucleus and transactivates phase II detoxifying and antioxidant genes \[[@B20]\]. The Nrf2 pathway is vital for the antioxidative response. Therefore, we examined whether STS promotes Nrf2 nuclear translocation, thereby inducing antioxidant gene expression. In the present study, H~2~O~2~ evoked a rapid and transient increase in Nrf2 activation. The increase of nucleus translocation of Nrf2 in H~2~O~2~-treated CSMC underlines the formation of oxidative stress induced by H~2~O~2~. In STS-treated CSMC, STS slightly stimulated Nrf2 translocation. In H~2~O~2~-treated CSMC, the pretreatment of STS promoted further translocation from the cytoplasm to the nucleus dose dependently. As expected, STS pretreatment significantly reduced the ROS production (MDA) and increased the expression of phase II antioxidant genes (HO-1, GSH, and SOD). Thus, STS could inhibit oxidative stress through the Nrf2/HO-1 pathway. These results are consistent with the findings of other study \[[@B11]\]. Since one of the known etiologies of ED is increased ROS formation in the cavernosum, STS could exert protective effect by inhibition of oxidative stress in hyperlipidemia-associated ED \[[@B23]\].

Studies using different species of animals\' and humans\' corpus cavernosum show evidence of H~2~S\'s proerectile effects \[[@B5], [@B7], [@B8]\]. Our results showed that plasma H~2~S levels were reduced in HFD rats, similar to a previous study \[[@B9]\]. However, H~2~S production and H~2~S-generating enzymes in the corpus cavernosum of hyperlipidemia animal model are rarely reported. We demonstrated that H~2~S production in penile tissues of rats with hyperlipidemia-associated ED was decreased, and STS treatment could alleviate the change. Similar to our findings, decreased H~2~S generation in penile tissues was accompanied by impaired erectile function, indicating the importance of H~2~S in maintaining sexual function \[[@B24], [@B25]\]. Our results also indicated that the expression of CSE and CBS was decreased in the HFD group, and STS treatment increased expression of these two H~2~S-generating enzymes, which can account for the H~2~S production changes. Interestingly, immunofluorescent staining showed that CBS and CSE which colocalize with *α*-SMA and calponin indicated that H~2~S-generating enzymes were mainly localized in the smooth muscle tissue in the cavernosum. Researchers also found similar results in human penile tissue \[[@B5]\]. Western blot experiments also showed the expression of 3-MST in the penile tissue, consistent with previous studies \[[@B24], [@B26]\]. Nevertheless, 3-MST expression did not change in penile tissues from rats with hyperlipidemia, indicating the downregulation of CSE and CBS might contribute to the decreased H~2~S production in the rats with hyperlipidemia. Since hyperlipidemia results in oxidative stress, to further clarify the role of oxidative stress in H~2~S formation, the expression of CSE and CBS and H~2~S levels in CSMC under oxidative stress were determined. Our data suggested that oxidative stress inhibited the expression of CSE and CBS, causing decreased H~2~S production. Similar to our findings, a study in fat-fed rat shows that vascular CSE expression is reduced during oxidative stress \[[@B9]\]. Further studies are warranted to identify the exact mechanism of this phenomenon.

5. Conclusion {#sec5}
=============

Our data suggest that hyperlipidemia and the related oxidative stress significantly reduced H~2~S production and CSE and CBS expression in vivo and in vitro. Treatment with STS may preserve erectile function by elevating the H~2~S formation and H~2~S-generating enzyme expression and enhancing antioxidant capacity via the Nrf2/HO-1 pathway in rats with hyperlipidemia.
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![Metabolic variables. (a) Body weight after 16 weeks\' feeding. (b) Serum lipid levels in each group. Each bar represents mean ± SEM; *N* = 12 rats per group. ^∗^*P* \< 0.05 compared to the NC group; ^∗∗^*P* \< 0.01 compared to the NC group; ^\#^*P* \< 0.05 compared with the HFD group.](OMCL2020-7286958.001){#fig1}

![Erectile function assessed by ICP/MAP. (a--c) Representative tracings of ICP in response to electrostimulation of cavernous nerve and MAP for each group. The black bar denotes the electrical stimulation. The red curve above denotes the MAP during the electrostimulation. (d, e) Erectile function is presented as ICP and ICP/MAP. Each bar represents mean ± SEM; *N* = 12 rats per group. ^∗^*P* \< 0.05 compared to the NC group; ^\#^*P* \< 0.05 compared with the HFD group.](OMCL2020-7286958.002){#fig2}

![*In vivo* H~2~S production. (a) *In vivo* H~2~S levels in blood. (b) *In vivo* H~2~S levels in penile tissue from each group. (c, d) H~2~S levels were assessed and visualized by a fluorescent H~2~S probe WSP-1 under a fluorescent microscope. Each bar represents mean ± SEM; *N* = 12 rats per group. ^∗^*P* \< 0.05 compared to the NC group; ^\#^*P* \< 0.05 compared with the HFD group.](OMCL2020-7286958.003){#fig3}

![Expression of CBS and CSE in the penile cavernous tissue. (a, b) Immunofluorescence staining for CBS and CSE in penile corpus cavernous tissue in each group. (c, d) Comparison of CBS and CSE expression in different groups. (e) Western blot analysis for CSE, CBS, and 3-MST. Each bar represents mean ± SEM; *N* = 12 rats per group. ^∗^*P* \< 0.05 compared to the NC group; ^\#^*P* \< 0.05 compared with the HFD group.](OMCL2020-7286958.004){#fig4}

![MDA content, antioxidant enzyme activities, and expression of Nrf2/HO-1. (a--c) MDA, GSH, and SOD levels in serum. (d--f) MDA, GSH, and SOD levels in penile corpus cavernous tissue. (g) Western blot analysis for Nrf2 and HO-1 in penile corpus cavernous tissue. (h) Immunofluorescence staining for HO-1 in the penile corpus cavernous tissue. Each bar represents mean ± SEM; *N* = 12 rats per group. ^∗^*P* \< 0.05 compared to the NC group; ^\#^*P* \< 0.05 compared with the HFD group.](OMCL2020-7286958.005){#fig5}

![Activation of the Nrf2/HO-1 pathway and antioxidant capacity in STS-pretreated CSMC. (a) Cell viability of STS-treated CSMC. Cells were treated with STS (0-60 *μ*g/ml) for 48 hours, and cell viability was measured by a CCK8 assay. (b) Cell viability of H~2~O~2~-treated CSMC. Cells were treated with H~2~O~2~ (50 *μ*M, 100 *μ*M, 200 *μ*M, and 400 *μ*M) for 6, 12, and 18 hours, and cell viability was measured. (c) Effect of STS pretreatment on the Nrf2/HO-1 pathway in H~2~O~2~-treated CSMC. The CSMC were treated with 100 *μ*M H~2~O~2~ for 12 hours with or without 2 hours of STS (1 *μ*g/ml, 5 *μ*g/ml, and 10 *μ*g/ml) pretreatment, and the expression of Nrf2 and HO-1 was determined by Western blot. (d, e) Effect of STS pretreatment on Nrf2 translocation in H~2~O~2~-treated CSMC. (f) Expression of HO-1 was measured by Western blot. (g, i) Effect of STS pretreatment on antioxidant capacity in H~2~O~2~-treated CSMC. The CSMC were treated with 100 *μ*M H~2~O~2~ for 12 hours with or without 2 hours of 10 *μ*g/ml STS pretreatment, and the MDA, GSH, and SOD levels were measured. Each bar represents mean ± SEM of three independent experiments; *N* = 3 per group. ^∗^*P* \< 0.05 compared to the NC group; ^∗∗^*P* \< 0.01 compared to the NC group; ^\#^*P* \< 0.05 compared with the H~2~O~2~ group; ^\#\#^*P* \< 0.01 compared with the H~2~O~2~ group.](OMCL2020-7286958.006){#fig6}

![H~2~S production in STS-pretreated CSMC. (a) Effect of STS pretreatment on H~2~S production in H~2~O~2~-treated CSMC. The CSMC were treated with 100 *μ*M H~2~O~2~ for 12 hours with or without 2 hours of STS (1 *μ*g/ml, 5 *μ*g/ml, and 10 *μ*g/ml) pretreatment. The H~2~S production was determined by methylene blue method. (b, c) Cellular H~2~S levels were assessed and visualized by a fluorescent H~2~S probe WSP-1. The CSMC were treated with 100 *μ*M H~2~O~2~ for 12 hours with or without 2 hours of 10 *μ*g/ml STS pretreatment, and WSP-1 florescent density was measured. Each bar represents mean ± SEM of three independent experiments; *N* = 3 per group. ^∗^*P* \< 0.05 compared to the NC group; ^∗∗^*P* \< 0.01 compared to the NC group; ^\#^*P* \< 0.05 compared with the H~2~O~2~ group; ^\#\#^*P* \< 0.01 compared with the H~2~O~2~ group.](OMCL2020-7286958.007){#fig7}

![Expression of CBS and CSE in STS-pretreated CSMC. (a--d) Immunofluorescence staining for CBS and CSE in CSMC. The CSMC were treated with 100 *μ*M H~2~O~2~ for 12 hours with or without 2 hours of 10 *μ*g/ml STS pretreatment. Effects of STS pretreatment on expression of CBS and CSE in H~2~O~2~-treated CSMC were detected by immunofluorescence staining. (e) Expression of CSE and CBS was measured by Western blot. Each bar represents mean ± SEM of three independent experiments; *N* = 3 per group. ^∗^*P* \< 0.05 compared to the NC group; ^\#^*P* \< 0.05 compared with the H~2~O~2~ group.](OMCL2020-7286958.008){#fig8}

###### 

Antibodies used in this study.

  --------------------------------- ---------------------- ----------------- ------------- ----------------------------------------------- --------------------------------
                                    *Primary antibody*     *Species/types*   *Dilution*    *Catalogue number*                              *Product information*

  H~2~S-generating enzyme markers   CSE                    Mouse mAb         IF 1 : 50\    60234-1-Ig                                      Proteintech, Rosemont, IL, USA
                                                                             WB 1 : 2000                                                   

  CBS                               Rabbit pAb             IF 1 : 50\        14787-1-AP    Proteintech, Rosemont, IL, USA                  
                                                           WB 1 : 2000                                                                     

  3-MST                             Rabbit pAb             WB 1 : 500        NBP1-82617    Novus Biologicals, Centennial, CO, USA          

  Antioxidant enzyme markers        Nrf2                   Rabbit pAb        WB 1 : 1000   ab137550                                        Abcam, Cambridge, MA, USA

  HO-1                              Rabbit pAb             IF 1 : 100\       27282-1-AP    Proteintech, Rosemont, IL, USA                  
                                                           WB 1 : 1500                                                                     

  Smooth muscle markers             *α*-SMA                Rabbit pAb        IF 1 : 50     14395-1-AP                                      Proteintech, Rosemont, IL, USA

  Calponin                          Mouse mAb              IF 1 : 50         sc-58707      Santa Cruz Biotechnology, Santa Cruz, CA, USA   

                                                                                                                                           

                                    *Secondary antibody*   *Types*           *Dilution*    *Catalogue number*                              *Product information*

  FITC conjugate                    Goat anti-mouse        IgG (H+L)         IF 1 : 50     SA00003-1                                       Proteintech, Rosemont, IL, USA

  Goat anti-rabbit                  IgG (H+L)              IF 1 : 50         SA00003-2     Proteintech, Rosemont, IL, USA                  

  Cy3 conjugate                     Goat anti-mouse        IgG (H+L)         IF 1 : 50     SA00009-1                                       Proteintech, Rosemont, IL, USA

  Goat anti-rabbit                  IgG (H+L)              IF 1 : 50         SA00009-2     Proteintech, Rosemont, IL, USA                  
  --------------------------------- ---------------------- ----------------- ------------- ----------------------------------------------- --------------------------------

IF: immunofluorescence; mAb: monoclonal antibody; pAb: polyclonal antibody; WB: Western blot.
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